Simcere Pharmaceutical Group Limited (FRA:S2P)
Germany flag Germany · Delayed Price · Currency is EUR
1.320
+0.010 (0.76%)
At close: Feb 20, 2026

FRA:S2P Ratios and Metrics

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Market Capitalization
3,5652,1952,0393,7102,6642,462
Market Cap Growth
71.56%7.63%-45.02%39.23%8.23%-
Enterprise Value
3,3931,9451,8773,5252,6172,829
Last Close Price
1.320.810.731.280.89-
PE Ratio
34.0822.6322.3729.3812.7729.36
PS Ratio
4.222.502.424.323.854.36
PB Ratio
4.152.352.213.832.983.68
P/TBV Ratio
5.262.812.514.163.103.89
P/FCF Ratio
28.9016.04-27.04--
P/OCF Ratio
21.5011.93105.8320.19-203.24
EV/Sales Ratio
4.012.222.234.113.785.01
EV/EBITDA Ratio
18.2410.8315.9031.8644.7629.79
EV/EBIT Ratio
22.5112.9720.6942.8581.0337.66
EV/FCF Ratio
27.5014.21-25.69--
Debt / Equity Ratio
0.170.170.200.210.250.62
Debt / EBITDA Ratio
0.790.841.431.723.504.10
Debt / FCF Ratio
1.191.17-1.49--
Net Debt / Equity Ratio
-0.20-0.10-0.08-0.16-0.080.01
Net Debt / EBITDA Ratio
-0.97-0.54-0.64-1.37-1.300.03
Net Debt / FCF Ratio
-1.39-0.711.77-1.101.33-0.10
Asset Turnover
0.580.590.610.600.470.51
Inventory Turnover
1.911.802.844.013.592.94
Quick Ratio
1.531.731.761.691.511.48
Current Ratio
1.732.002.101.841.631.85
Return on Equity (ROE)
12.45%10.26%9.94%13.62%25.41%19.49%
Return on Assets (ROA)
6.50%6.33%4.11%3.62%1.38%4.23%
Return on Invested Capital (ROIC)
19.48%15.63%10.83%10.15%4.14%11.15%
Return on Capital Employed (ROCE)
13.90%12.90%8.70%7.80%3.30%8.10%
Earnings Yield
2.93%4.42%4.47%3.40%7.83%3.41%
FCF Yield
3.46%6.23%-2.08%3.70%-2.14%-1.30%
Dividend Yield
1.48%2.61%2.80%1.69%2.33%-
Payout Ratio
45.61%54.76%58.65%42.04%25.96%-
Buyback Yield / Dilution
4.18%3.40%0.45%-0.34%-9.14%-2.03%
Total Shareholder Return
5.65%6.01%3.25%1.34%-6.81%-2.03%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.